LBO — UPPER CHESAPEAKE MEDICAL CENTER
IRR: 30.9% | MOIC: 3.84x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
30.9%
IRR
3.84x
MOIC
$83.8M
Entry EV
$206.2M
Exit EV
$43.1M
Equity Invested
Sources & Uses
S&UTotal · $83.8M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $32.5M | 38.8% | |
| Sub Debt | $8.1M | 9.7% | |
| Equity | $43.1M | 51.5% | |
| Enterprise Value | $81.4M | 97.1% | |
| Transaction Fees | $2.4M | 2.9% | |
| Total Uses | $83.8M | 100.0% |
Interpretation
INTAt 3.84x MOIC and 30.9% IRR over 5 years, this deal exceeds the typical 20% hurdle — strong candidate.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $19.6M |
| Exit Ev | $206.2M |
| Net Debt At Exit | $40.7M |
| Equity At Exit | $165.5M |
| Equity Invested | $43.1M |
| Total Value Created | $122.4M |
| Value From Growth | $120.8M |
| Value From Multiple | $4.1M |
| Value From Deleveraging | 0.0% |